Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin in Antiretroviral Naive Patients Co-infected With HIV and Tuberculosis in India.

Trial Profile

Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin in Antiretroviral Naive Patients Co-infected With HIV and Tuberculosis in India.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Mar 2013

At a glance

  • Drugs Nevirapine (Primary) ; Efavirenz; Lamivudine/zidovudine; Rifampicin
  • Indications HIV infections; Tuberculosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Mar 2013 New trial record
    • 01 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top